Skip to main content

The Windows of Susceptibility to Breast Cancer

  • Chapter
  • First Online:
The Pathobiology of Breast Cancer

Abstract

The occurrence of cancer of the breast has long been known [1–4] and the disease affects women of all races and nationalities and the incidence of has increased 30–40 % since the 1970s [2, 4–7]. This already dismal picture is worsened by the gradual increase in breast cancer incidence in most Western countries and in societies that recently became westernized or that are in the process of westernization [8, 9]. Epidemiological observations that daughters of women who migrate from low-incidence to high-incidence countries acquire the breast cancer risk prevailing in the new country [10], suggest that aspects of lifestyle or the environment are major determinants of breast cancer risk. A study of population-attributable risks has estimated that at least 45 % to 55 % of breast cancer cases in the United States may be explained by the following factors: advanced age at the time of the first full-term pregnancy, nulliparity, family history of breast cancer, higher socioeconomic status, earlier age at menarche, and prior benign breast disease [11]. Other statistical models appear to explain an even higher proportion of breast cancer on the basis of known risk factors [12]. Studies of atomic bomb survivors have shown that environmental exposures, such as ionizing radiation, are a risk factor for breast cancer [13]. Exposure to radiation at a young age (Fig. 1.1) has been identified as a causative agent of breast cancer in selected populations [14–17], but there is no definitive proof of what causes breast cancer in the population at large. The increased risk associated with exposure to environmental chemicals, such as alcohol [18] and cigarette smoke [19–25], makes these agents suspects for causing cancer in the human population (Fig. 1.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Breasted JH (ed) (1991) The Edwin Smith Surgical Papyrus: published in facsimile and hieroglyphic transliteration with translation and commentary in two volumes, vol 1. University of Chicago Press, Chicago

    Google Scholar 

  2. Clarke CA, Purdie DM, Glaser SL (2006) Population attributable risk of breast cancer in white women associated with immediately modifiable risk factors. BMC Cancer 6:170

    Article  PubMed  PubMed Central  Google Scholar 

  3. Botha JL, Bray F, Sanlika R, Parkin DM (2003) Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 39:1718–1729

    Article  CAS  PubMed  Google Scholar 

  4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Google Scholar 

  5. Nagata C, Mizoue T, Tanaka K, Tsuji I, Wakai K, Inoue M et al (2006) Tobacco smoking and breast cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol 36:387–394

    Article  PubMed  Google Scholar 

  6. Maskarinec G, Pagano I, Chen Z, Nagata C, Gram IT (2007) Ethnic and geographic differences in mammographic density and their association with breast cancer incidence. Breast Cancer Res Treat 104:47–56

    Article  PubMed  Google Scholar 

  7. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA (2005) Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 34:405–412

    Article  PubMed  Google Scholar 

  8. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ (2003) Cancer Statistics, 2003. CA Cancer J Clin 53:5–26

    Article  PubMed  Google Scholar 

  9. Howe HL, Wingo PA, Thun MJ, Ries LA, Rosenberg HM, Feigal EG, Edwards BK (2001) Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 93:824–842

    Article  CAS  PubMed  Google Scholar 

  10. Buell P (1973) Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst 51:1479–1483

    CAS  PubMed  Google Scholar 

  11. Madigan MP, Ziegler RG, Benichou J, Byrne C, Hooper RN (1995) Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 87:1681–1685

    Article  CAS  PubMed  Google Scholar 

  12. Colditz GA, Frazier AL (1995) Models of breast cancer show that risk is set of events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev 4:567–571

    CAS  PubMed  Google Scholar 

  13. Segaloff A, Maxfield WS (1971) The synergism between radiation and estrogen in the production of mammary cancer in the rat. Cancer Res 31:166

    CAS  PubMed  Google Scholar 

  14. Hancock SL, Tucker MA, Hoppe RT (1993) Breast cancer after treatment of Hodgkin’s disease. J Natl Cancer Inst 85:25–31

    Article  CAS  PubMed  Google Scholar 

  15. Cutuli B, Borel C, Dhermain F, Magrini SM, Wasserman TH, Bogart JA, Provencio M, de Lafontan B, de la Rochefordiere A, Cellai E, Graic Y, Kerbrat P, Alzieu C, Teissier E, Dilhuydy J, Mignotte H, Velten M (2001) Breast cancer occurred after treatment for Hodgkin’s disease: analysis of 133 cases. Radiother Oncol 59:247–255

    Article  CAS  PubMed  Google Scholar 

  16. Gaffney DK, Hemmersmeier J, Holden J, Marshall J, Smith LM, Avizonis V, Tran T, Neuhausen SL (2001) Breast cancer after mantle irradiation for Hodgkin’s disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2. Int J Radiat Oncol Biol Phys 49:539–546

    Article  CAS  PubMed  Google Scholar 

  17. Janov AJ, Tulecke M, O’Neill A, Lester S, Mauch PM, Harris J, Schnitt SJ, Shapiro CL (2001) Clinical and pathologic features of breast cancers in women treated for Hodgkin’s disease: a case-control study. Breast J 7:46–52

    Article  CAS  PubMed  Google Scholar 

  18. Lash TL, Aschengrau A (2000) Alcohol drinking and risk of breast cancer. Breast J 6:396–399

    Article  PubMed  Google Scholar 

  19. Spangler JG, Michielutte R, Bell RA, Dignan MB (2001) Association between smokeless tobacco use and breast cancer among Native-American women in North Carolina. Ethn Dis 11:36–43

    CAS  PubMed  Google Scholar 

  20. Satcher D (2001) Women and health: a report of the Surgeon General - 2001. U.S. Dept. Health and Human Serv., PHS Office of the Surgeon General, 1–4

    Google Scholar 

  21. Russo IH, Tahin Q, Huang Y, Russo J (2001) Cellular and molecular changes induced by the chemical carcinogen benzo(a)pyrene in human breast epithelial cells and its association with smoking and breast cancer. J Women Cancer 3:29–36

    Google Scholar 

  22. Baron JA (2001) Breast cancer, hormone-related disorders and cigarette smoking. J Women Cancer 3:23–28

    Google Scholar 

  23. Phillips DH, Martin FL, Grover PL, Williams JA (2001) Toxicological basis for a possible association of breast cancer with smoking and other sources of environmental carcinogens. J Women Cancer 3:9–16

    Google Scholar 

  24. Ambrosone CB (2001) Impact of genetics on the relationship between smoking and breast cancer risk. J Women Cancer 3:17–22

    Google Scholar 

  25. Morabia A, Ambrosone CB, Baron JA, Phillips DH, Russo IH (2001) What do we currently know about the epidemiological and biologic plausibility of the association of smoking and breast cancer? J Women Cancer 3:5–8

    Google Scholar 

  26. Blot WJ, Fraumeni JF, Stone BJ (1977) Geographic patterns of breast cancer in the United States. J Natl Cancer Inst 59:1407–1411

    CAS  PubMed  Google Scholar 

  27. Sturgeon SR, Schairer C, Gail M, McAdams M, Brinton LA, Hoover RN (1995) Geographic variation in mortality from breast cancer among white women in the United States. J Natl Cancer Inst 87:1846–1853

    Article  CAS  PubMed  Google Scholar 

  28. Nasca PC, Mahoney MC, Wolfgang PE (1992) Population density and cancer incidence differentials in New York State. Cancer Causes Control 3:7–15

    Article  CAS  PubMed  Google Scholar 

  29. Robbins AS, Brescianini S, Kelsey JL (1997) Regional differences in known risk factors and the higher incidence of breast cancer in San Francisco. J Natl Cancer Inst 89:960–965

    Article  CAS  PubMed  Google Scholar 

  30. Clarke CA, Glaser SL, West DW, Ereman RR, Erdmann CA, Barlow JM, Wrensch MR (2002) Breast cancer incidence and mortality trends in an affluent population: Marin County, California, USA, 1990–1996. Breast Cancer Res 4:R13

    Article  PubMed  PubMed Central  Google Scholar 

  31. Garland FC, Garland CF, Gorham ED, Young JF (1990) Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure in solar radiation. Prev Med 19:614–622

    Article  CAS  PubMed  Google Scholar 

  32. Eisman JA, McIntyre I, Marti TJ, Frampton RJ, King RJ, King RJ (1980) Normal and malignant breast tissue is a target organ for 1,25-(OH)2 vitamin D3. Clin Endocrinol 13:267–272

    Article  CAS  Google Scholar 

  33. Gorham ED, Garland FC, Garland CF (1990) Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 19:820–824

    Article  CAS  PubMed  Google Scholar 

  34. National Council on Radiation Protection and Measurements (1987) Ionizing radiation exposures of the population of the United States. Rep. 93, Natl. Counc. Radiation. Prot. Meas., Washington, D.C.

    Google Scholar 

  35. McGregor DH, Land CE, Choi K, Tokuoka S, Liu PI, Wakabayashi I, Beebe GW (1977) Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki 1950–1989. J Natl Cancer Inst 59:799–811

    CAS  PubMed  Google Scholar 

  36. Boice JD Jr, Preston D, Davis FG, Monson RR (1991) Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res 125:214–222

    Article  PubMed  Google Scholar 

  37. Boice JD Jr, Land CE, Preston DL (1996) Ionizing radiation. In: Scottenfeld DL, Fraumedni JF Jr (eds) Cancer epidemiology and prevention, 2nd edn. Oxford Univ. Press, New York, pp 319–372

    Google Scholar 

  38. National Academy Press (1990) Health effects of exposure to low levels of ionizing radiation (BIER V). National Academy Press, Washington, D.C., 421 pp

    Google Scholar 

  39. Brenner DJ, Sawant SG, Hande MP, Miller RC, Elliston CD, Fu Z, Randers-Pehrson G, Marino SA (2002) Routine screening mammography: how important is the radiation-risk side of the benefit-risk equation? Int J Radiat Biol 78:1065–1067

    Article  CAS  PubMed  Google Scholar 

  40. U.S. Department of Energy (1996) Energy Information Administration. The changing structure of the Electric Power Industry; An Updata Rep. DOE/EIA-0562(96). U.S. Dept. Energy, Washington, D.C.

    Google Scholar 

  41. Stevens RG (1987) Electric power use and breast cancer: a hypothesis. Am J Epidemiol 125:556–561

    CAS  PubMed  Google Scholar 

  42. Tamarkin L, Baird CJ, Almeida OF (1985) Melatonin: a coordinating signal for mammalian reproduction? Science 227:714–720

    Article  CAS  PubMed  Google Scholar 

  43. Wurtman RJ, Axelrod J (1965) The pineal gland. Sci Am 213:50–60

    Article  CAS  PubMed  Google Scholar 

  44. Reiter RJ (1994) Melatonin suppression by static and extremely low frequency electromagnetic fields: relationship to the reported increased incidence of cancer. Rev Environ Health 10:171–186

    Article  CAS  PubMed  Google Scholar 

  45. Baum A, Mevissen M, Kamino K, Mohr U, Loscher W (1995) A histopathological study on alterations in DMBA-induced mammary carcinogenesis in rats with 50 Hz, 100 muT magnetic field exposure. Carcinogenesis 16:119–125

    Article  CAS  PubMed  Google Scholar 

  46. Liburdy RP, Loscher W (1997) Laboratory studies on extremely low frequency (50/60-Hz) magnetic fields and carcinogenesis. In: Stevens RG, Wilson BW, Anderson LE (eds) The melatonin hypothesis, breast cancer and use of electric power. Batelle Press, Columbus, pp 585–668

    Google Scholar 

  47. Liburdy RP, Sloma TR, Sokolic R, Yaswen P (1993) ELF magnetic fields, breast cancer, and melatonin: 60 Hz fields block melatonin’s oncostatic action on ER + breast cancer cell proliferation. J Pineal Res 14:84–97

    Article  Google Scholar 

  48. Loscher W, Mevissen M (1994) Mini-review: animal studies on the role of 50/60-Hertz magnetic fields in carcinogenesis. Life Sci 54:1531–1543

    Article  CAS  PubMed  Google Scholar 

  49. Wertheimer N, Leeper E (1987) Magnetic field exposure related to cancer subtypes. Ann NY Acad Sci 502:43–54

    Article  CAS  PubMed  Google Scholar 

  50. Florig HK, Hoburg JF (1990) Power-frequency magnetic fields from electric blankets. Health Phys 58:493–502

    Article  CAS  PubMed  Google Scholar 

  51. Preston-Martin S, Peters JM, Yu MC, Garabrant DH, Bowman JD (1988) Myelogenous leukemia and electric blanket use. Bioelectromagnetics 9:207–213

    Article  CAS  PubMed  Google Scholar 

  52. Vena JE, Freudenheim JL, Marshall R Jr, Laughlin R, Swanson M, Graham S (1994) Risk of premenopausal breast cancer and use of electric blankets. Am J Epidemiol 140:974–979

    CAS  PubMed  Google Scholar 

  53. Moysich KB, Ambrosone CB, Vena JE, Kostyniak P, Shields PG et al (1997) Serum polychlorinated biphenyls (PCBs) and postmenopausal breast cancer risk. Proc Am Assoc Cancer Res 38:627a

    Google Scholar 

  54. Kutz FW, Wood PH, Bottimore DP (1991) Organochlorine pesticides and polychlorinated biphenyls in human adipose tissue. Rev Environ Contam Toxicol 120:1–82

    CAS  PubMed  Google Scholar 

  55. Adami H-O, Lipworth L, Titus-Ernstoff L, Hsieh C-C, Hanberg A et al (1995) Organo-chlorine compounds and estrogen-related cancers in women. Cancer Causes Control 6:551–566

    Article  CAS  PubMed  Google Scholar 

  56. Ahlborg UG, Lipworth L, Titus-Ernstoff L, Hsieh C-C, Hanberg A et al (1995) Organo-chlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol 25:463–531

    Article  CAS  PubMed  Google Scholar 

  57. Wolff MS, Collman GW, Barrett JC, Huff J (1996) Breast cancer and environmental risk factors: epidemiological and experimental findings. Annu Rev Pharmacol Toxicol 36:573–596

    Article  CAS  PubMed  Google Scholar 

  58. Bergthorsson JT, Ejlertsen B, Olsen JH, Borg A, Nielsen KV, Barkardottir RB, Klausen S, Mouridsen HT, Winther K, Fenger K, Niebuhr A, Harboe TL, Niebuhr E (2001) BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age. J Med Genet 38:361–368

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Greenblatt MS, Chappuis PO, Bond JP, Hamel N, Foulkes WD (2001) TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution. Cancer Res 61:4092–4097

    CAS  PubMed  Google Scholar 

  60. Lehman TA, Haffty BG, Carbone CJ, Bishop LR, Gumbs AA, Krishnan S, Shields PG, Modali R, Turner BC (2000) Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer. Cancer Res 60:1062–1069

    CAS  PubMed  Google Scholar 

  61. Kelsey JL, Horn-Ross PL (1993) Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev 15:7–16

    CAS  PubMed  Google Scholar 

  62. MacMahon B, Cole P, Lin TM et al (1970) Age at first birth and breast cancer risk. Bull World Health Organ 43:209–217

    CAS  PubMed  PubMed Central  Google Scholar 

  63. Vessey MD, McPherson K, Roberts MM, Neil A, Jones L (1985) Fertility and the risk of breast cancer. Br J Cancer 52:625–628

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Trapido EJ (1983) Age at first birth, parity and breast cancer risk. Cancer 51:946–948

    Article  CAS  PubMed  Google Scholar 

  65. De Waard F, Trichopoulos D (1988) A unifying concept of the etiology of breast cancer. Int J Cancer 41:666–669

    Article  PubMed  Google Scholar 

  66. Lambe M, Hsieh CC, Chan HW, Ekbom A, Trichopoulos D, Adami HO (1996) Parity, age at first and last birth, and risk of breast cancer: a population-based study in Sweden. Breast Cancer Res Treat 38:305–311

    Article  CAS  PubMed  Google Scholar 

  67. Meiser B, Butow P, Barratt A, Friedlander M, Gattas M, Kirk J, Suthers G, Walpole I, Tucker K (1999) Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. Gynecol Oncol 75:122–129

    Article  CAS  PubMed  Google Scholar 

  68. Feychting M, Osterlund B, Ahlbom A (1998) Reduced cancer incidence among the blind. Epidemiology 9:490–494

    Article  CAS  PubMed  Google Scholar 

  69. Wurtman RJ (1984) Fall of nocturnal melatonin during puberty and prepubescence. Lancet 362:85

    Google Scholar 

  70. Dauchy RT, Blask DE, Sauer LA, Brainard GC, Krause JA (1999) Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. Cancer Lett 144:131–136

    Article  CAS  PubMed  Google Scholar 

  71. Tamarkin L, Cohen M, Roselle D, Reichert C, Lippman M, Chabner B (1981) Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. Cancer Res 44:4432–4436

    Google Scholar 

  72. Pillittere D, Miller M (2000) Researchers search for link between circadian rhythms, breast cancer. J Natl Cancer Inst 92:686–689

    Article  CAS  PubMed  Google Scholar 

  73. Bernstein L, Hanisch R, Sullivan-Halley J, Ross RK (1995) Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 4:437–440

    CAS  PubMed  Google Scholar 

  74. Russo IH, Russo J (1996) Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 104:938–967

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Rao GN, Piegorsch WW, Haseman JK (1987) Influence of body weight on the incidence of spontaneous tumors in rats and mice of long term studies. Am J Clin Nutr 45:252–260

    CAS  PubMed  Google Scholar 

  76. Huggins C, Briziarelli G, Sutton H (1959) Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J Exp Med 709:25–42

    Article  Google Scholar 

  77. Huggins C, Grand L, Fukunishi R (1964) Aromatic influences in the yields of mammary cancers following administration of 7,12-dimethylbenzanthracene. Proc Natl Acad Sci U S A 57:737–742

    Article  Google Scholar 

  78. Gullino PM, Pettigrew HM, Grantham FH (1975) N-nitrosomethylurea as mammary gland carcinogen in rats. J Natl Cancer Inst 54:401–414

    CAS  PubMed  Google Scholar 

  79. Thordarson G, Lee AV, McCarty M, Van Horn K, Chu O, Chou YC et al (2001) Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats. Carcinogenesis 22:2039–2047

    Article  CAS  PubMed  Google Scholar 

  80. Medina D, Kittrell FS, Hill J, Shepard A, Thordarson G, Brown P (2005) Tamoxifen inhibition of estrogen receptor-α–negative mouse mammary tumorigenesis. Cancer Res 65:3493–3496

    CAS  PubMed  Google Scholar 

  81. Russo J, Russo IH (1987) Development of human mammary gland. In: Neville MC, Daniel C (eds) The mammary gland development, regulation and function. Plenum Publishing Corp, New York, pp 67–93

    Chapter  Google Scholar 

  82. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, Van Zwieten MJ (1990) Comparative study of human and rat mammary tumorigenesis. Lab Invest 62:1–32

    Google Scholar 

  83. Russo J, Russo IH (eds) (2004) Molecular basis of breast cancer: prevention and treatment. Springer Verlag, Berlin

    Google Scholar 

  84. Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH et al (2011) Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 103:1–8

    Article  Google Scholar 

  85. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Article  PubMed  Google Scholar 

  86. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B et al (1970) Age at first birth and breast cancer risk. Bull World Health Organ 43:209–221

    CAS  PubMed  PubMed Central  Google Scholar 

  87. Hinkula M, Pukkala E, Kyyrönen P, Kauppila A (2001) Grand multiparity and the risk of breast cancer: population-based study in Finland. Cancer Causes Control 12:491–500

    Article  CAS  PubMed  Google Scholar 

  88. Ma H, Henderson KD, Sullivan-Halley J, Duan L, Marshall SF, Ursin G et al (2010) Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Breast Cancer Res 12:R35

    Article  PubMed  PubMed Central  Google Scholar 

  89. Toniolo P, Grankvist K, Wulff M, Chen T, Johansson R, Schock H et al (2010) Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer. Cancer Res 70:6779–6786

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Mustacchi P (1961) Ramazzini and Rigoni-Stern on parity and breast cancer. Clinical impression and statistical corroboration. Arch Intern Med 108:639–642

    Article  CAS  PubMed  Google Scholar 

  91. Kroman N, Mouridsen HT (2003) Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer. Breast 12:516–521

    Article  PubMed  Google Scholar 

  92. Kroman N, Melbye M, Mouridsen HT (2002) Prognostic influence of age at diagnosis in premenopausal breast cancer patients. Scand J Surg 91:305–308

    CAS  PubMed  Google Scholar 

  93. Welsch CW (1985) Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 45:3415–3443

    CAS  PubMed  Google Scholar 

  94. Moral R, Wang R, Russo IH, Lamartiniere CA, Pereira J, Russo J (2008) Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature. J Endocrinol 196:101–112

    Article  CAS  PubMed  Google Scholar 

  95. Kawaguchi H, Miyoshi N, Miyamoto Y, Souda M, Umekita Y, Yasuda N et al (2009) Effects of fetal exposure to diethylstilbestrol on mammary tumorigenesis in rats. J Vet Med Sci 71:1599–1608

    Article  CAS  PubMed  Google Scholar 

  96. Umekita Y, Souda M, Hatanaka K, Hamada T, Yoshioka T, Kawaguchi H et al (2011) Gene expression profile of terminal end buds in rat mammary glands exposed to diethylstilbestrol in neonatal period. Toxicol Lett 205:15–25

    Article  CAS  PubMed  Google Scholar 

  97. Goodman A, Schorge J, Greene MF (2011) The long-term effects of in utero exposures–the DES story. N Engl J Med 364:2083–2084

    Article  CAS  PubMed  Google Scholar 

  98. Russo IH, Russo J (2007) Primary prevention of breast cancer by hormone-induced differentiation. Recent Results Cancer Res 174:111–130

    Article  CAS  PubMed  Google Scholar 

  99. Russo J, Tait L, Russo IH (1983) Susceptibility of the mammary gland to carcinogenesis: III the cell of origin of rat mammary carcinoma. Am J Pathol 113:50–66

    CAS  PubMed  PubMed Central  Google Scholar 

  100. Russo J, Balogh GA, Chen J, Fernandez SV, Fernbaugh R, Heulings R et al (2006) The concept of stem cell in the mammary gland and its implication in morphogenesis, cancer and prevention. Front Biosci 11:151–172

    Article  CAS  PubMed  Google Scholar 

  101. Bennett DC, Peachey LA, Durbin H, Rudland PS (1978) A possible mammary stem cell line. Cell 15:283–298

    Article  CAS  PubMed  Google Scholar 

  102. Bussard KM, Smith GH (2011) The mammary gland microenvironment directs progenitor cell fate in vivo. Int J Cell Biol. doi:10.1155/2011/451676

    PubMed  PubMed Central  Google Scholar 

  103. Hernandez-Gonzalez M, Juarez J (2000) Alcohol before puberty produces an advance in the onset of sexual behavior in male rats. Alcohol 21(2):133–140

    Article  CAS  PubMed  Google Scholar 

  104. Harris C (2001) Tobacco smoking and cancer risk in women. J Women Cancer 3:1–4

    Google Scholar 

  105. Russo J, Barnabas N, Higgy N, Salicioni AM, Wu YL, Russo IH (1996) Molecular basis of human breast cell transformation. In: Calvo F, Crepin M, Magdelenat H (eds) Advances in breast cancer research. Eurotext, Paris, pp 33–43

    Google Scholar 

  106. Stevens RG, Davis S, Mirick DK, Kheifets L, Kaune W (2000) Alcohol consumption and urinary concentration of 6-sulfatoxymelatonin in healthy women. Epidemiology 11(6):660–665

    Article  CAS  PubMed  Google Scholar 

  107. Falcon J (1999) Cellular circadian clocks in the pineal [Review]. Prog Neurobiol 58:121–162

    Article  CAS  PubMed  Google Scholar 

  108. Beatson GT (1896) On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet ii:104

    Article  Google Scholar 

  109. Jordan VC (1976) Effect of tamoxifen (ICI 46,474) on the initiation and growth of DMBA-induced rat mammary carcinoma. Eur J Cancer 12:419–424

    Article  CAS  PubMed  Google Scholar 

  110. Russo IH, Koszalka M, Gimotty PA, Russo J (1990) Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis. Br J Cancer 62:243–247

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  111. Russo IH, Koszalka M, Russo J (1991) Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Br J Cancer 64:481–484

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Blakely CM, Stoddard AJ, Belka GK, Dugan KD, Notarfrancesco KL, Moody SE et al (2006) Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Res 66:6421–6431

    Article  CAS  PubMed  Google Scholar 

  113. Medina D, Kittrell FS (2003) p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis. Cancer Res 63:6140–6143

    CAS  PubMed  Google Scholar 

  114. Rajkumar L, Kittrell FS, Guzman RC, Brown PH, Nandi S, Medina D (2007) Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models. Breast Cancer Res 9:R12

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  115. Weroha SJ, Li SA, Tawfik O, Li JJ (2006) Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats. Carcinogenesis 27:491–498

    Article  CAS  PubMed  Google Scholar 

  116. Li SA, Weroha SJ, Tawfik O, Li JJ (2002) Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen r eceptor mediation. J Endocrinol 175:297–305

    Article  CAS  PubMed  Google Scholar 

  117. Russo J, Fernandez SV, Russo PA, Fernbaugh R, Sheriff FS, Lareef HM, Garber J, Russo IH (2006) 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J 20:1622–1634

    Article  CAS  PubMed  Google Scholar 

  118. Chen T, Lundin E, Grankvist K, Zeleniuch-Jacquotte A, Wulff M, Afanasyeva Y et al (2010) Maternal hormones during early pregnancy: a cross-sectional study. Cancer Causes Control 21:719–727

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  119. Lukanova A, Surcel HM, Lundin E, Kaasila M, Lakso HA, Schock H et al (2011) Circulating estrogens and progesterone during primiparous. pregnancies and risk of maternal breast cancer. Int J Cancer 130:910–920

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  120. Russo IH, Gimotty P, Dupuis M, Russo J (1989) Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis. Br J Cancer 59:210–216

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Lanari C, Lamb CA, Fabris VT, Helguero LA, Soldati R, Bottino MC et al (2009) The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer. Endocr Relat Cancer 16:333–350

    Article  CAS  PubMed  Google Scholar 

  122. Russo J, Rivera R, Russo IH (1992) Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 23:211–218

    Article  CAS  PubMed  Google Scholar 

  123. Lathi RB, Fisher SJ, Giudice LC (2006) Implantation and placental physiology in early human pregnancy: the role of the maternal decidua and the trophoblast. In: De Groot L, Jameson LJ (eds) Endocrinology. Elsevier Saunders, Philadelphia, pp 3341–3351

    Google Scholar 

  124. Parry S, Strauss F III (2006) Placental hormones. In: De Groot L, Jameson LJ (eds) Endocrinology. Elsevier Saunders, Philadelphia, pp 3353–3367

    Google Scholar 

  125. Alvarado MV, Ho T-Y, Russo J, Russo IH (1994) Human chorionic gonadotropin regulates the synthesis of inhibin in the ovary and the mammary gland of rats. Endocrine 2:1–10

    Google Scholar 

  126. Alvarado ME, Alvarado NE, Russo J, Russo IH (1994) Human chorionic gonadotropin inhibits proliferation and induces expression of inhibin in human breast epithelial cells in vitro. In Vitro 30A:4–8

    CAS  Google Scholar 

  127. Horikoshi Y, Matsumoto H, Takatsu Y, Ohtaki T, Kitada C, Usuki S et al (2003) Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab 88:914–919

    Article  CAS  PubMed  Google Scholar 

  128. Johnson KC, Miller AB, Collishaw NE, Palmer JR, Hammond SK, Salmon AG et al (2011) Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tob Control 20, e2

    Article  PubMed  Google Scholar 

  129. Johansson AL, Andersson TM, Hsieh CC, Cnattingius S, Lambe M (2011) Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum. Cancer Epidemiol Biomarkers Prev 20:1865–1872

    Article  PubMed  Google Scholar 

  130. Hahn RA, Moolgavkar SH (1989) Nulliparity, decade of first birth, and breast cancer in Connecticut cohorts, 1855 to 1945: an ecological study. Am J Public Health 79:1503–1507

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  131. Mathews TJ, Hamilton BE (2009) Delayed childbearing: more women are having their first child later in life. National Center for Health Statistics data brief No. 21, Hyattsville, MD

    Google Scholar 

  132. Lakshmanaswamy R, Guzman RC, Nandi S (2008) Hormonal prevention of breast cancer: significance of promotional environment. Adv Exp Med Biol 617:469–475

    Article  CAS  PubMed  Google Scholar 

  133. Balogh GA, Heulings R, Mailo DA, Russo PA, Sheriff F, Russo IH et al (2006) Genomic signature induced by pregnancy in the human breast. Int J Oncol 28:399–410

    CAS  PubMed  Google Scholar 

  134. Russo J, Balogh GA, Russo IH (2008) Full-term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol Biomarkers Prev 17:51–66

    Article  CAS  PubMed  Google Scholar 

  135. George K, Kamath MS (2010) Fertility and age. J Hum Reprod Sci 3:121–123

    Article  PubMed  PubMed Central  Google Scholar 

  136. Homan GF, Davies M, Norman R (2007) The impact of lifestyle factors on reproductive performance in the general population and those undergoing infertility treatment. Hum Reprod Update 13:209–223

    Article  CAS  PubMed  Google Scholar 

  137. Downs JL, Wise PM (2009) The role of the brain in female reproductive aging. Mol Cell Endocrinol 299:32–38

    Article  CAS  PubMed  Google Scholar 

  138. Russo IH, Medado J, Russo J (1989) Endocrine influences on mammary gland structure and development. In: Jones TC, Mohr U, Hunt RD (eds) Integument and mammary gland of laboratory animals. Springer Verlag, Berlin, pp 252–266

    Chapter  Google Scholar 

  139. Gleicher N, Weghofer A, Barad DH (2011) Defining ovarian reserve to better understand ovarian aging. Reprod Biol Endocrinol 9:23

    Article  PubMed  PubMed Central  Google Scholar 

  140. Danforth DR, Arbogast LK, Mroueh J, Kim MH, Kennard EA, Seifer DB et al (1998) Dimeric inhibin: a direct marker of ovarian ageing. Fertil Steril 70:119–123

    Article  CAS  PubMed  Google Scholar 

  141. Rance NE (2009) Menopause and the human hypothalamus: evidence for the role of kisspeptin/neurokinin B neurons in the regulation of estrogen negative feedback. Peptides 30:111–122

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Russo, J. (2016). The Windows of Susceptibility to Breast Cancer. In: The Pathobiology of Breast Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-40815-6_1

Download citation

Publish with us

Policies and ethics